# Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

> **NCT01140412** · PHASE1 · TERMINATED · sponsor: **ViiV Healthcare** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Maraviroc
- **DRUG:** Fosamprenavir/ritonavir
- **DRUG:** Maraviroc + Fosamprenavir/ritonavir
- **DRUG:** Maraviroc
- **DRUG:** Fosamprenavir/ritonavir
- **DRUG:** Maraviroc + Fosamprenavir/ritonavir

## Key facts

- **NCT ID:** NCT01140412
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The trial prematurely terminated on November 1, 2010, due to healthy volunteer participants experiencing non-serious fosamprenavir-related skin rash.
- **Last updated:** 2011-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140412, "Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT01140412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*